China Pharma Holdings, Inc. Announces Updated Dial-In Information For Its Fiscal Year 2013 Earnings Conference Call
Published: Mar 21, 2014
HAIKOU CITY, China, March 21, 2014 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, announced today updated dial-in information for its fiscal year 2013 earnings conference call. Below is the updated information.
Fiscal Year Conference Call
Friday, March 21, 2014
8:30 a.m. ET
US Toll Free: 1 800 742 9301
US Toll Free: 1 855 452 5696
Conference ID 8557805
A replay of the call will be accessible through March 28, 2014.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a specialty pharmaceutical company that develops, manufactures and markets a diversified portfolio of products focused on conditions with a high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high-margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding nationwide distribution network across all major cities and provinces in China. The Company's wholly-owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd., is located in Haikou City, Hainan Province. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com. The Company routinely posts important information on its website.
China Pharma Holdings, Inc.
SOURCE China Pharma Holdings, Inc.
Help employers find you! Check out all the jobs and post your resume.